BioVie Inc (BIVI)
0.4943
+0.01
(+1.62%)
USD |
NASDAQ |
May 07, 16:00
0.4943
0.00 (0.00%)
After-Hours: 20:00
BioVie Enterprise Value: 9.362M for May 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 06, 2024 | 9.362M |
May 03, 2024 | 9.521M |
May 02, 2024 | 9.900M |
May 01, 2024 | 9.625M |
April 30, 2024 | 9.506M |
April 29, 2024 | 9.705M |
April 26, 2024 | 9.298M |
April 25, 2024 | 9.462M |
April 24, 2024 | 10.12M |
April 23, 2024 | 9.577M |
April 22, 2024 | 9.234M |
April 19, 2024 | 9.366M |
April 18, 2024 | 9.442M |
April 17, 2024 | 8.764M |
April 16, 2024 | 9.426M |
April 15, 2024 | 9.613M |
April 12, 2024 | 10.32M |
April 11, 2024 | 9.717M |
April 10, 2024 | 8.556M |
April 09, 2024 | 8.513M |
April 08, 2024 | 8.748M |
April 05, 2024 | 9.091M |
April 04, 2024 | 9.553M |
April 03, 2024 | 9.773M |
April 02, 2024 | 10.92M |
Date | Value |
---|---|
April 01, 2024 | 12.32M |
March 28, 2024 | 11.04M |
March 27, 2024 | 11.24M |
March 26, 2024 | 11.14M |
March 25, 2024 | 12.54M |
March 22, 2024 | 12.92M |
March 21, 2024 | 12.60M |
March 20, 2024 | 14.54M |
March 19, 2024 | 15.06M |
March 18, 2024 | 15.74M |
March 15, 2024 | 18.09M |
March 14, 2024 | 16.50M |
March 13, 2024 | 18.21M |
March 12, 2024 | 16.38M |
March 11, 2024 | 17.67M |
March 08, 2024 | 18.60M |
March 07, 2024 | 19.68M |
March 06, 2024 | 23.07M |
March 05, 2024 | 25.96M |
March 04, 2024 | 32.43M |
March 01, 2024 | 65.32M |
February 29, 2024 | 39.41M |
February 28, 2024 | 39.81M |
February 27, 2024 | 40.60M |
February 26, 2024 | 39.01M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
8.513M
Minimum
Apr 09 2024
611.77M
Maximum
Feb 03 2021
118.98M
Average
95.40M
Median
Jan 10 2022
Enterprise Value Benchmarks
Adial Pharmaceuticals Inc | 3.701M |
Precision BioSciences Inc | -20.54M |
Cardiff Oncology Inc | 87.56M |
Jaguar Health Inc | 119.52M |
First Wave BioPharma Inc | 2.166M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -8.401M |
Total Expenses (Quarterly) | 8.781M |
EPS Diluted (Quarterly) | -0.22 |
Earnings Yield | -236.7% |